Twist Bioscience Corp Earnings

Twist Bioscience Corp’s revenue jumped 26.53% since last year same period to $84.71Mn in the Q3 2024. On a quarterly growth basis, Twist Bioscience Corp has generated 3.98% jump in its revenue since last 3-months.

Twist Bioscience Corp’s net profit jumped 25.06% since last year same period to $-34.66Mn in the Q3 2024. On a quarterly growth basis, Twist Bioscience Corp has generated 59.5% jump in its net profits since last 3-months.

Twist Bioscience Corp’s net profit margin jumped 40.77% since last year same period to -40.91% in the Q3 2024. On a quarterly growth basis, Twist Bioscience Corp has generated 61.05% jump in its net profit margins since last 3-months.

Twist Bioscience Corp’s earning per share (EPS) estimates for the current quarter stand at -0.69 - a 9.96% jump from last quarter’s estimates.

Twist Bioscience Corp’s earning per share (EPS) estimates for the current year stand at -0.69.

Twist Bioscience Corp’s earning per share (EPS) jumped 27.16% since last year same period to -0.59 in the Q3 2024. This indicates that the Twist Bioscience Corp has generated 27.16% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Twist Bioscience Corp’s return on assets (ROA) stands at -0.16.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Twist Bioscience Corp’s return on equity (ROE) stands at -0.38.